Nomogram for predicting risk of arm lymphedema following axillary lymph node dissection in breast cancer patients
This study developed and internally validated a predictive model that integrates modern treatment modalities (NAC, HER2-targeted therapy, SCRT) with traditional risk factors to identify high-risk BCRaL patients undergoing ALND and chemotherapy. The model requires external validation in future studies. Consequently, the nomogram presents a potential tool for strategizing precision prevention, necessitating further evaluation before its broader adoption in clinical practice.
Authors
- Lihui Pan (ORCID: https://orcid.org/0000-0002-7327-1392)
- Hai‐Bo Yang (ORCID: https://orcid.org/0000-0003-4926-1618)
- Jinnan Gao (ORCID: https://orcid.org/0000-0002-9163-9453)
- Miaomiao Jia (ORCID: https://orcid.org/0000-0001-7282-1535)
- Xiaojun Zhang (ORCID: https://orcid.org/0009-0003-2354-5353)
- Wenzhuang Shen
Institutions
- Shanxi Academy of Medical Sciences (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-11-21
- DOI
- https://doi.org/10.3389/fonc.2025.1667939
- Primary Topic
- Lymphatic System and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sun Yat-sen University